newsfilter
← Latest News
ACCESS Newswire·

NovAccess Global to Present at World Orphan Drug Congress

CLEVELAND, OH / ACCESSWIRE / February 16, 2023 / NovAccess Global Inc. , a biomedical company developing novel immunotherapies for brain tumor patients, today announced that its CEO Dr. Dwain Irvin has been